LL.M., University of California, Berkeley, School of Law (Boalt Hall)
LL.M. Program, National Chiao-Tung University, Institute of Technology Law
Master’s degree in Biotechnology, National Taiwan University
Speaker for the “Pharmaceutical Patent Linkage System Promotion & Legal Education” seminar series held by Food and Drug Administration (2020 to 2022)
Speaker for “biotech legal practice courses” held by Development Center for Biotechnology (2022)
Speaker for corporate governance and intellectual property courses held by Corporate Operating and Sustainable Development Association (from 2021)
Chair of Biotechnology Practice Committee, Taiwan Patent Attorneys Association (2020 to 2021)
Speaker for “Advanced IP Litigation Practice” held by Taiwan Intellectual Property Training Academy (2019)
Speaker for “Technology Counseling and Promotion for Pharmaceutical Industry - Patent Training” held by Pharmaceutical Industry Technology Development Center (2019)
Review Committee member for a project sponsored by Ministry of Economic Affairs (2019)
Admitted to Practice：
Patent Attorney
“The Battle between Generic Drug Companies and Brand-Name Drug Companies,” Economic Daily News (June 2012).
“International Patent Litigation from the Perspective of Smart Phone Wars,” Law +Business@LCS (January 2012).
“Patent Assigned or Licensed? IP Bank Should Clarify,” Economic Daily News (November 2011).
“Defendant’s Weapon in Patent Litigations,” Economic Daily News (July 2011).
“Practical Issues in the New IP Law” (co-author), Commercial Times (March 2007).
[Expert’s Commentary of the Commercial Times] Moderna initiates vaccine patent fight, September 2022
[Expert’s Commentary of the Commercial Times] Brexit and the management of your intellectual property rights, January 2021
Co-Author of "Legal Affairs for Business People", COMMERCIAL CULTURE CO., LTD., Dec. 2022
